Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease

被引:11
|
作者
Mapel, Douglas W. [1 ]
Roberts, Melissa H. [1 ]
Sama, Susan [2 ]
Bobbili, Priyanka J. [3 ]
Cheng, Wendy Y. [3 ]
Duh, Mei Sheng [3 ]
Nguyen, Catherine [3 ]
Thompson-Leduc, Philippe [3 ]
Van Dyke, Melissa K. [4 ]
Rothnie, Kieran J. [4 ]
Sundaresan, Devi [2 ]
Certa, Julia M. [5 ]
Whiting, Thomas S. [5 ]
Brown, Jennifer L. [5 ]
Roblin, Douglas W. [5 ]
机构
[1] Univ New Mexico, Coll Pharm, 2502 Marble Ave, Albuquerque, NM 87106 USA
[2] Reliant Med Grp Inc, Worcester, MA USA
[3] Anal Grp Inc, Boston, MA USA
[4] GlaxoSmithKline Plc, London, England
[5] Midatlantic Permanente Res Inst MAPRI, Kaiser Permanente Midatlantic States KPMAS, Rockville, MD USA
关键词
claims database; algorithm; validation; electronic medical records; predictive values; AECOPD events; QUALITY-OF-LIFE; UNITED-STATES; COPD; COSTS; DIAGNOSIS; OUTCOMES; BURDEN;
D O I
10.2147/COPD.S302241
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are important events that may precipitate other adverse outcomes. Accurate AECOPD event identification in electronic administrative data is essential for improving population health surveillance and practice management. Objective: Develop codified algorithms to identify moderate and severe AECOPD in two US healthcare systems using administrative data and electronic medical records, and validate their performance by calculating positive predictive value (PPV) and negative predictive value (NPV). Methods: Data from two large regional integrated health systems were used. Eligible patients were identified using International Classification of Diseases (Ninth Edition) COPD diagnosis codes. Two algorithms were developed: one to identify potential moderate AECOPD by selecting outpatient/emergency visits associated with AECOPD-related codes and antibiotic/systemic steroid prescriptions; the other to identify potential severe AECOPD by selecting inpatient visits associated with corresponding codes. Algorithms were validated via patient chart review, adjudicated by a pulmonologist. To estimate PPV, 300 potential moderate AECOPD and 250 potential severe AECOPD events underwent review. To estimate NPV, 200 patients without any AECOPD identified by the algorithms (100 patients each without moderate or severe AECOPD) during the two years following the index date underwent review to identify AECOPD missed by the algorithm (false negatives). Results: The PPVs (95% confidence interval [CI]) for both moderate and severe AECOPD were high: 293/298 (98.3% [96.1-99.5]) and 216/225 (96.0% [92.5-98.2]), respectively. NPV was lower for moderate AECOPD (75.0% [65.3-83.1]) than for severe AECOPD (95.0% [88.7-98.4]). Results were consistent across both healthcare systems. Conclusion: This study developed healthcare utilization-based algorithms to identify moderate and severe AECOPD in two separate healthcare systems. PPV for both algorithms was high; NPV was lower for the moderate algorithm. Replication and consistency of results across two healthcare systems support the external validity of these findings.
引用
收藏
页码:1687 / 1698
页数:12
相关论文
共 50 条
  • [21] Role of Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease; Outcomes and Healthcare Utilization
    Munshi, R.
    Pellegrini, J.
    Patel, P.
    Anjum, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S141 - S142
  • [22] Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States
    Klinger, James R.
    Wu, Benjamin
    Morland, Kellie
    Classi, Peter
    Fiano, Ryan
    Grabich, Shannon
    RESPIRATORY MEDICINE, 2023, 219
  • [23] Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Emergency Department
    Brulotte, Cory A.
    Lang, Eddy S.
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2012, 30 (02) : 223 - +
  • [24] Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease
    Ben Abdallah, Fatma Chermiti
    Bouhawel, Wafa
    Sahnoun, Imen
    Mahouachi, Ridha
    Chtourou, Amel
    Taktak, Sofia
    Ben Kheder, Ali
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [25] Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease
    Pilcher, Janine
    Weatherall, Mark
    Perrin, Kyle
    Beasley, Richard
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (03) : 287 - 293
  • [26] Inflammasome activity in acute exacerbations of chronic obstructive pulmonary disease
    Kardara, Matina
    Dima, Efrossini
    Giannakopoulou, Harilena
    Vakali, Sofia
    Roussos, Charis
    Koulouris, Nikolaos
    Rovina, Nikoletta
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [27] Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)
    Burgel, P. -R.
    MEDECINE ET MALADIES INFECTIEUSES, 2006, 36 (11-12): : 706 - 717
  • [28] Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease
    Carlos A. Camargo
    Adit A. Ginde
    Sunday Clark
    Charles P. Cartwright
    Ann R. Falsey
    Dennis E. Niewoehner
    Internal and Emergency Medicine, 2008, 3
  • [29] TREATMENT OF ACUTE EXACERBATIONS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    ROSEN, RL
    BONE, RC
    MEDICAL CLINICS OF NORTH AMERICA, 1990, 74 (03) : 691 - 700
  • [30] Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease
    Brill, Simon E.
    Wedzicha, Jadwiga A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 1241 - 1252